Organization

Eli Lilly and Company

6 members

What's driving coverage of Eli Lilly and Company right now?

Corporate ratings

High Risk

Eli Lilly is rated high risk because it scored poorly across several corporate bias categories, including discriminatory philanthropy, employment protection, advocacy bias, funding, and political actions. The company is seen as prioritizing identity-based and politically driven initiatives over merit-based practices and core business objectives, raising concerns about governance and stakeholder alienation.

CancellationsMedium Risk
Discriminatory PhilanthropyHigh Risk
Employment ProtectionHigh Risk
Advocacy BiasHigh Risk
FundingHigh Risk
Political ActionsHigh Risk

6 memberscoverage spread: L38/C38/R25

Comments

Ask this entity anything:

Free account · your comment posts right after signup

Eli Lilly and Company

6 members

What's driving coverage of Eli Lilly and Company right now?

Corporate ratings

High Risk

Eli Lilly is rated high risk because it scored poorly across several corporate bias categories, including discriminatory philanthropy, employment protection, advocacy bias, funding, and political actions. The company is seen as prioritizing identity-based and politically driven initiatives over merit-based practices and core business objectives, raising concerns about governance and stakeholder alienation.

CancellationsMedium Risk
Discriminatory PhilanthropyHigh Risk
Employment ProtectionHigh Risk
Advocacy BiasHigh Risk
FundingHigh Risk
Political ActionsHigh Risk

6 memberscoverage spread: L38/C38/R25

Comments

Ask this entity anything:

Free account · your comment posts right after signup

Board Bias

David A. Ricks (CEO & Chairman) - Republican Support $385,250, Democratic Support $113,137

Assessment by 1792 Exchange. Summary generated by IJR from their published rating.

64 sources

Health

Lilly Retatrutide Meets Endpoints in Phase 3 Trials

Eli Lilly announced positive Phase 3 results for retatrutide in TRIUMPH-2 and TRIUMPH-3, showing substantial weight loss and improved metabolic and cardiovascular risk markers, with average losses ranging roughly from the high 20s to the mid-50s pounds across different doses. The company plans to submit a Biologics License Application to the FDA in early 2027 as it moves toward global regulatory submissions for obesity and related conditions.

7 sources

Eli Lilly and Company across IJR

Ask Genius about Eli Lilly and Company Create in Studio Build a game Watch videos

Eli Lilly and Company, doing business as Lilly, is an American multinational pharmaceutical company headquartered in Indianapolis, Indiana, with offices in 18 countries. Its products are sold in approximately 125 countries. The company was founded in 1876 by Eli Lilly, a pharmaceutical chemist and Union army veteran during the American Civil War for whom the company was later named.

Overview

Eli Lilly and Company, doing business as Lilly, is an American multinational pharmaceutical company headquartered in Indianapolis, Indiana, with offices in 18 countries. Its products are sold in approximately 125 countries. The company was founded in 1876 by Eli Lilly, a pharmaceutical chemist and Union army veteran during the American Civil War for whom the company was later named.

From Wikipedia (CC BY-SA 4.0).

Eli Lilly and Company across IJR

Ask Genius about Eli Lilly and Company Create in Studio Build a game Watch videos

Eli Lilly and Company

Corporate ratings

Comments

FDA approves Alzheimer's blood test for age 40+

UK Approves Foundayo Oral GLP-1 Pill; NHS Decision Pending

Eli Lilly and Company

Corporate ratings

Comments

FDA approves Alzheimer's blood test for age 40+

UK Approves Foundayo Oral GLP-1 Pill; NHS Decision Pending

Overview

Lilly Retatrutide Meets Endpoints in Phase 3 Trials

Eli Lilly and Company across IJR

Overview

Eli Lilly and Company across IJR